Login Register Cart 0
Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Study of the Relationship Between Insulin Resistance, Iron Status Markers, and Body Weight in a Sample of Egyptian Population

Author(s): Ahmed Mohamed Bahaaeldin, Magda Shoukry Hussein, Shaimaa Shaaban Hashem and Amr Mahmoud Mohamed Saleh*

Volume 20, Issue 4, 2024

Published on: 26 September, 2023

Article ID: e170823219896 Pages: 8

DOI: 10.2174/1573399820666230817102053

Price: $65

Abstract

Background: Iron plays a key role in the regulation of body iron homeostasis and is used as a clinical marker for iron deficiency (ID) and hemochromatosis. The idea that iron dysregulation may contribute to various metabolic diseases, such as obesity, insulin resistance, MetS, and T2DM, is a hot topic of discussion.

Aim: The aim of this study is to investigate the relationship insulin resistance, iron status markers, and body weight in a sample of Egyptian population.

Methods: A case control study was conducted on 90 subjects with age ranging from 18 to 70 years old from a diabetes outpatient clinic, and they were divided to three groups: Group I, non-obese- non-diabetic as the control group; Group II, obese-non-diabetic; and Group III, obese-diabetic.

Results: In our study, there was no statistically significant difference between the three studied groups regarding the different iron parameters. Similarly, we found that neither HOMA-IR nor body weight had a significant correlation with iron status markers. On the contrary, we detected significant positive correlations between the TIBC and the fasting blood glucose, between the serum iron and the LDL, between the TSAT and the systolic blood pressure, and between the HOMA-IR and hematocrit.

Conclusion: Our study demonstrated no direct statistical significant relationship between the different iron parameters, obesity, and insulin resistance, either in the diabetic or non-diabetic subjects. This may be due to the complex metabolic dysregulation and the small number of the sample for future investigations.

[1]
Aigner E, Feldman A, Datz C. Obesity as an emerging risk factor for iron deficiency. Nutrients 2014; 6(9): 3587-600.
[http://dx.doi.org/10.3390/nu6093587] [PMID: 25215659]
[2]
Wondmkun YT. Obesity, insulin resistance, and type 2 diabetes: Associations and therapeutic implications. Diabetes Metab Syndr Obes 2020; 13: 3611-6.
[http://dx.doi.org/10.2147/DMSO.S275898] [PMID: 33116712]
[3]
Simcox JA, McClain DA. Iron and diabetes risk. Cell Metab 2013; 17(3): 329-41.
[http://dx.doi.org/10.1016/j.cmet.2013.02.007] [PMID: 23473030]
[4]
Chen G, Li M, Xu Y, et al. Impact of family history of diabetes on β-cell function and insulin resistance among Chinese with normal glucose tolerance. Diabetes Technol Ther 2012; 14(6): 463-8.
[http://dx.doi.org/10.1089/dia.2011.0245] [PMID: 22404096]
[5]
Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002; 48(3): 436-72.
[http://dx.doi.org/10.1093/clinchem/48.3.436] [PMID: 11861436]
[6]
Eastham RD. Biochemical values in clinical medicine 7th. Bristol, England: John Wright & Sons, Ltd 1985.
[7]
Walters GO, Miller FM, Worwood M. Serum ferritin concentration and iron stores in normal subjects. J Clin Pathol 1973; 26(10): 770-2.
[http://dx.doi.org/10.1136/jcp.26.10.770] [PMID: 4750458]
[8]
Wang Q, Jokelainen J, Auvinen J, et al. Insulin resistance and systemic metabolic changes in oral glucose tolerance test in 5340 individuals: An interventional study. BMC Med 2019; 17(1): 217.
[http://dx.doi.org/10.1186/s12916-019-1440-4] [PMID: 31779625]
[9]
Wu H, Ballantyne CM. Metabolic inflammation and insulin resistance in obesity. Circ Res 2020; 126(11): 1549-64.
[http://dx.doi.org/10.1161/CIRCRESAHA.119.315896] [PMID: 32437299]
[10]
Kundu D, Mandal T, Ghosh E, Ray D, Roy A, Bandyopadhyay U. Relation of iron stores to oxidative stress in type 2 diabetes. Niger J Clin Pract 2013; 16(1): 100-3.
[http://dx.doi.org/10.4103/1119-3077.106776] [PMID: 23377481]
[11]
Lin HY, Weng SW, Chang YH, et al. The causal role of mitochondrial dynamics in regulating insulin resistance in diabetes: Link through mitochondrial reactive oxygen species. Oxid Med Cell Long 2018; 2018: 7514383.
[12]
Liu J, Li Q, Yang Y, Ma L. Iron metabolism and type 2 diabetes mellitus: A meta‐analysis and systematic review. J Diabetes Investig 2020; 11(4): 946-55.
[http://dx.doi.org/10.1111/jdi.13216] [PMID: 31975563]
[13]
Zhao Z, Li S, Liu G, et al. Body iron stores and heme-iron intake in relation to risk of type 2 diabetes: A systematic review and meta-analysis. PLoS One 2012; 7(7): e41641.
[http://dx.doi.org/10.1371/journal.pone.0041641] [PMID: 22848554]
[14]
Lee BK, Kim Y, Kim YI. Association of serum ferritin with metabolic syndrome and diabetes mellitus in the South Korean general population according to the korean national health and nutrition examination survey 2008. Metabolism 2011; 60(10): 1416-24.
[http://dx.doi.org/10.1016/j.metabol.2011.02.008] [PMID: 21489582]
[15]
Kunutsor SK, Apekey TA, Walley J, Kain K. Ferritin levels and risk of type 2 diabetes mellitus: An updated systematic review and meta-analysis of prospective evidence. Diabetes Metab Res Rev 2013; 29(4): 308-18.
[http://dx.doi.org/10.1002/dmrr.2394] [PMID: 23381919]
[16]
Ortíz Pérez M, Vázquez López MA, Ibáñez Alcalde M, et al. Relationship between obesity and iron deficiency in healthy adolescents. Child Obes 2020; 16(6): 440-7.
[http://dx.doi.org/10.1089/chi.2019.0276] [PMID: 32877290]
[17]
Abo Zeid AA, El Saka MH, Abdalfattah AA, Zineldeen DH. Potential factors contributing to poor iron status with obesity. Alex J Med 2014; 50(1): 45-8.
[http://dx.doi.org/10.1016/j.ajme.2013.04.007]
[18]
Bataju M, Bhattarai B, Niraula A, Priyadarshinee A, Gautam S. Study of correlation between iron deficiency anemia and serum lipid profile in a tertiary care center. Nepal Med J 2021; 4(1): 446-9.
[http://dx.doi.org/10.3126/nmj.v4i1.38480]
[19]
Zhu Y, Chen G, Bo Y, Liu Y. Markers of iron status, blood pressure and incident hypertension among Chinese adults. Nutr Metab Cardiovasc Dis 2019; 29(8): 830-6.
[http://dx.doi.org/10.1016/j.numecd.2019.04.012] [PMID: 31255378]
[20]
Kim MK, Baek KH, Song KH, et al. Increased serum ferritin predicts the development of hypertension among middle-aged men. Am J Hypertens 2012; 25(4): 492-7.
[http://dx.doi.org/10.1038/ajh.2011.241] [PMID: 22278211]
[21]
Feng L, Chen H, Chen J, et al. The product of red blood cells and hematocrit can be used as a novel indicator of impaired fasting blood glucose status. Diabetes Metab Syndr Obes 2020; 13: 4007-15.
[http://dx.doi.org/10.2147/DMSO.S270276] [PMID: 33149640]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy